Inhibitory effect of pentoxifylline and prostaglandin E1 on the release of neutrophil elastase from FMLP-stimulated neutrophils. 1991

Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
Second Department of Surgery, Osaka University Medical School, Japan.

We measured the enzymatic and immunologic activities of neutrophil elastase to determine whether pentoxifylline and prostaglandin E1 are useful for inhibiting the enzymatic activity of released neutrophil elastase. Both activities in the medium decrease in the presence of pentoxifylline and prostaglandin E1. These results showed that pentoxifylline and prostaglandin E1 inhibited the release of neutrophil elastase from activated neutrophils, and that they may be useful in the improvement of neutrophil-mediated cellular injury.

UI MeSH Term Description Entries
D009240 N-Formylmethionine Leucyl-Phenylalanine A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. F-Met-Leu-Phe,N-Formyl-Methionyl-Leucyl-Phenylalanine,Formylmet-Leu-Phe,Formylmethionyl Peptide,Formylmethionyl-Leucyl-Phenylalanine,Formylmethionylleucylphenylalanine,N-Formylated Peptide,N-formylmethionyl-leucyl-phenylalanine,fMet-Leu-Phe,F Met Leu Phe,Formylmet Leu Phe,Formylmethionyl Leucyl Phenylalanine,Leucyl-Phenylalanine, N-Formylmethionine,N Formyl Methionyl Leucyl Phenylalanine,N Formylated Peptide,N Formylmethionine Leucyl Phenylalanine,N formylmethionyl leucyl phenylalanine,Peptide, Formylmethionyl,Peptide, N-Formylated,fMet Leu Phe
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D010431 Pentoxifylline A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. Agapurin,BL-191,Oxpentifylline,Pentoxil,Torental,Trental,BL 191,BL191
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D019272 Leukocyte Elastase An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37. Lysosomal Elastase,Neutrophil Elastase,PMN Elastase,Polymorphonuclear Leukocyte Elastase,Granulocyte Elastase,Elastase, Granulocyte,Elastase, Leukocyte,Elastase, Lysosomal,Elastase, Neutrophil,Elastase, PMN,Elastase, Polymorphonuclear Leukocyte,Leukocyte Elastase, Polymorphonuclear
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
December 1990, Biochemical pharmacology,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
October 1994, Prostaglandins, leukotrienes, and essential fatty acids,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
June 2007, Journal of leukocyte biology,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
January 2006, Pharmacology,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
July 2003, International archives of allergy and immunology,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
January 1979, Acta physiologica Academiae Scientiarum Hungaricae,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
November 1980, Prostaglandins and medicine,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
June 1978, British journal of experimental pathology,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
April 1986, Agents and actions,
Y Oka, and A Murata, and J Nishijima, and N Hiraoka, and T Yasuda, and K Kitagawa, and M Ogawa, and T Mori
August 1974, Endocrinology,
Copied contents to your clipboard!